Your browser doesn't support javascript.
loading
A case report of appendix mucinous adenocarcinoma that recurred after additional surgery and a brief literature review.
Chen, Wei; Ye, Jun-Wen; Tan, Xiao-Ping; Peng, Xiang; Zhang, Yan; Liang, Jing-Lin; Huang, Mei-Jin.
Afiliación
  • Chen W; Department of Colorectal Surgery, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510655, People's Republic of China.
  • Ye JW; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510655, China.
  • Tan XP; Guangdong Research Institute of Gastroenterology, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510655, China.
  • Peng X; Department of Colorectal Surgery, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510655, People's Republic of China.
  • Zhang Y; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510655, China.
  • Liang JL; Guangdong Research Institute of Gastroenterology, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510655, China.
  • Huang MJ; Department of Emergency, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510655, China.
BMC Surg ; 20(1): 182, 2020 Aug 10.
Article en En | MEDLINE | ID: mdl-32778094
ABSTRACT

BACKGROUND:

The clinical incidence of appendiceal mucinous adenocarcinoma is low. Moreover, the case reports of postoperative relapse after surgery are rarely based on literature search results. Here, we report such a case spanning nearly 7 years and and review the relevant literature. CASE PRESENTATION A 50-year-old female underwent additional surgery after appendectomy, and pathological examination confirmed mucinous adenocarcinoma. The patients underwent HIPEC (hyperthermic intraoperative chemotherapy) and adjuvant chemotherapy. Twenty-six months after the previous surgeries, another surgery, HIPEC, and adjuvant chemotherapy were performed again due to tumour recurrence. To date, the follow-up time is 43 months, and no recurrence or metastasis has been found.

CONCLUSIONS:

Appendix mucinous adenocarcinoma has a poor prognosis and the diagnosis depends on pathological and immunohistochemical examinations. Its clinical manifestations are non-specific, and CRS + HIPEC should be used for treatment, which is safe and effective.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Apéndice / Apéndice / Neoplasias Peritoneales / Adenocarcinoma Mucinoso / Hipertermia Inducida Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: BMC Surg Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Apéndice / Apéndice / Neoplasias Peritoneales / Adenocarcinoma Mucinoso / Hipertermia Inducida Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: BMC Surg Año: 2020 Tipo del documento: Article